Recommended Vaccinations for HIV-Positive and Immunocompromised Patients
HIV-positive individuals and those on immunosuppressive treatment have a higher risk of complications from vaccine-preventable diseases. Certain vaccines are strongly recommended — and some live vaccines are contraindicated. Dr. Monga advises the right vaccination schedule based on your immune status.
Important Note: No HIV Vaccine Exists
As of 2025, there is no approved vaccine that prevents HIV infection. The vaccines listed below prevent other serious infections — not HIV itself. This page is about protecting HIV-positive and immunocompromised individuals from vaccine-preventable diseases.
Why Vaccinations are Especially Important for HIV-Positive Individuals
HIV weakens the immune system — specifically the CD4 T-cells that coordinate immune responses. This means HIV-positive individuals are at significantly higher risk of severe complications from infections that a healthy immune system would manage relatively well. Pneumonia, influenza, hepatitis B, and other vaccine-preventable diseases can cause serious illness or death in immunocompromised patients that might cause only a mild illness in someone with a healthy immune system.
An additional consideration: some live-attenuated vaccines (vaccines containing weakened live virus) are contraindicated in severely immunocompromised patients (CD4 < 200) because the live virus could cause disease rather than prevent it. Knowing which vaccines are safe at which CD4 count is a specialist-level decision that Dr. Monga makes based on each patient's immune status.
Vaccination should ideally happen as early as possible after HIV diagnosis — before immune function declines significantly — as vaccine responses are better when CD4 counts are higher (ideally above 200 cells/mm³).
Need expert consultation for HIV Prevention, HIV Testing, STD Screening & HIV Counselling?
Confidential, specialist-level care — 100% discreet.
Recommended Vaccines for HIV-Positive Patients
Hepatitis B Vaccine
Hepatitis B is a liver infection that can become chronic in immunocompromised individuals. All HIV-positive individuals who are not already immune to Hepatitis B should receive the full 3-dose series. An additional test (anti-HBs titre) after the series confirms adequate immune response — if the response is inadequate (common in immunocompromised patients), additional doses are given.
Schedule: 3-dose series: 0, 1, and 6 months. Titre check after series.
Influenza Vaccine (Annual)
Influenza can cause severe, life-threatening illness in HIV-positive individuals. Annual influenza vaccination with inactivated influenza vaccine (IIV) is strongly recommended. Note: the live-attenuated intranasal influenza vaccine (LAIV/FluMist) is contraindicated in HIV-positive individuals — only inactivated injectable influenza vaccine should be used.
Schedule: Annually, preferably before influenza season (October–November in India).
Pneumococcal Vaccine (PCV & PPSV23)
Streptococcus pneumoniae (pneumococcus) causes pneumonia, meningitis, and bloodstream infections — all significantly more dangerous in immunocompromised patients. Both protein conjugate vaccine (PCV15 or PCV20) and the polysaccharide vaccine (PPSV23) are recommended, given in sequence. The regimen depends on vaccination history and CD4 count.
Schedule: PCV followed by PPSV23 at least 8 weeks later. Revaccination considered at 5 years.
HPV Vaccine (Human Papillomavirus)
HIV-positive individuals — especially women and men who have sex with men — have a higher risk of HPV-related cancers (cervical, anal, oropharyngeal, and others). The HPV vaccine is recommended for HIV-positive individuals up to age 26, and can be considered up to age 45 after specialist counselling.
Schedule: 3-dose series for immunocompromised: 0, 1–2 months, 6 months.
Meningococcal Vaccine
Meningococcal disease (bacterial meningitis) is more severe in immunocompromised patients. Both quadrivalent meningococcal vaccine (MenACWY) and meningococcal B vaccine (MenB) are recommended for HIV-positive individuals, particularly those with low CD4 counts or receiving immunosuppressive therapy.
Schedule: 2-dose primary series (MenACWY); discuss MenB timing with specialist.
Td/Tdap (Tetanus, Diphtheria, Pertussis)
Standard adult boosters recommended for all adults apply to HIV-positive individuals — with the inactivated vaccine formulation. Tdap is given once (to replace a single Td booster), then Td every 10 years. These are inactivated vaccines and safe regardless of CD4 count.
Schedule: Tdap once if not previously received; Td every 10 years.
Hepatitis A Vaccine
Hepatitis A vaccination is recommended for HIV-positive individuals who are Hepatitis A seronegative and at risk — this includes men who have sex with men, travellers to endemic areas, and those with liver disease.
Schedule: 2-dose series: 0 and 6–12 months.
Varicella (Chickenpox) / Herpes Zoster — Special Caution
⚠ Caution RequiredLive vaccines for varicella and shingles require careful consideration: the live-attenuated varicella vaccine is generally safe for HIV-positive individuals with CD4 ≥ 200. The recombinant zoster vaccine (Shingrix) is safe and preferred over the live zoster vaccine. The live zoster vaccine (Zostavax) is CONTRAINDICATED in severely immunocompromised patients. Specialist assessment required before any zoster vaccination.
Schedule: Specialist assessment required. Shingrix (2 doses) preferred for eligible patients.
How Dr. Monga Advises on Vaccination
Dr. Monga reviews each patient's vaccination history, current CD4 count, viral load, and specific medical history before recommending a vaccination schedule. For newly diagnosed patients, a complete vaccination review is part of the initial HIV management plan. For patients already on ART, vaccination review is incorporated into regular follow-up consultations.
Home sample collection for pre-vaccination serology (e.g., Hepatitis B antibody testing, Varicella serology) is available to ensure vaccines are given only when needed and to check post-vaccination immune response.
Need expert consultation for HIV Prevention, HIV Testing, STD Screening & HIV Counselling?
Confidential, specialist-level care — 100% discreet.
Book a Consultation
Book a Confidential Consultation
Our counsellor will call within 15 minutes.
Dr. Yuvraj Arora Monga
MBBS, MD (Pharmacology)
Fellowship in Infectious Diseases
Chief Consultant Physician & CEO
Consultation Fee
₹2,000
Prescription included
"Need doctor consultation for HIV, STD & AIDS? We provide expert counselling, consultation, testing, and treatment services to help you."